Zobrazeno 1 - 7
of 7
pro vyhledávání: '"O G, Yurin"'
Autor:
N. V. Sizova, I. O. Modestova, F. F. Shakhova, N. V. Koplevskaya, O. A. Klitsenko, A. V. Kravchenko, O. G. Yurin, D. A. Gusev
Publikováno v:
Журнал инфектологии, Vol 9, Iss 3, Pp 61-66 (2017)
In 20 patients, treated with regime of ART including phosphazid at a dose of 800 mg/day, his daily dose was reduced to 400 mg. In 19 of 20 patients the phosphazod’ dose reduction was due to the development of adverse events related to therapy. Afte
Externí odkaz:
https://doaj.org/article/1c152debe87549e1b76393e3ff0bac75
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 63-66 (2017)
As part of the global strategy against HIV, UNAIDS formulated the 90-90--90 targets. The targets mean that 90% of people living with HIV and receiving treatment should have achieved viral suppression. One of the main obstacles to achieving the goal i
Externí odkaz:
https://doaj.org/article/3ce689fed9c048ebadcafa1171b942a0
Autor:
O. G. YURIN, O. S. EFREMOVA
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 67-72 (2017)
The guidelines for treatment of patients with HIV infection developed in the United States (DHHS) and the European Union (EACS) are the most globally recognised. They are used in the development of many national guidelines, including those in Russia.
Externí odkaz:
https://doaj.org/article/5821d79d2fbf4ee29fba260d724069d8
Publikováno v:
Терапевтический архив, Vol 88, Iss 11, Pp 12-16 (2016)
Aim. To study the sociodemographic data of people living with HIV who visit AIDS centers. Subjects and methods. A multicenter open-label study was conducted, which included the retrospective model “A patient’s portrait”. Outpatient records and
Externí odkaz:
https://doaj.org/article/fd451afc669c478da73ce8396196346e
Publikováno v:
Терапевтический архив, Vol 81, Iss 4, Pp 64-68 (2009)
Aim. To study efficacy and safety of highly active antiretrovirus treatment (HAAT) used in the Russian Federation for development of recommendations for HIV infection treatment. Material and methods. A total of 285 patients with chronic HIV infection
Externí odkaz:
https://doaj.org/article/847e45d0a35c483880dd7e33631f0df0
Autor:
D. A. Gusev, I. O. Modestova, A. V. Kravchenko, F. F. Shakhova, O. G. Yurin, N. V. Sizova, N. V. Koplevskaya, O. A. Klitsenko
Publikováno v:
Žurnal Infektologii, Vol 9, Iss 3, Pp 61-66 (2017)
In 20 patients, treated with regime of ART including phosphazid at a dose of 800 mg/day, his daily dose was reduced to 400 mg. In 19 of 20 patients the phosphazod’ dose reduction was due to the development of adverse events related to therapy. Afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c48d870fa2f867527fc6f01433309bca
https://journal.niidi.ru/jofin/article/view/634
https://journal.niidi.ru/jofin/article/view/634
Publikováno v:
Terapevticheskii arkhiv. 86(11)
To study the duration of the natural course of HIV infection and to identify its influencing factors.938 outpatient case histories of adult HIV-positive patients registered at the dispensary and the data of 3403 AIDS patients registered in the comput
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6cc3ca28223a32f2d86f13201ec00a90
https://pubmed.ncbi.nlm.nih.gov/25715482
https://pubmed.ncbi.nlm.nih.gov/25715482